Results 101 to 110 of about 192,633 (312)

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2011
Aim of investigation. To study the role of serological markers of hepatitis B virus infection: antibodies to hepatitis B virus cor-antigen (anti-HВcor IgG) in progressing liver damage at patients with persistent hepatitis C virus infection.Material and ...
Ye. N. German, M. V. Mayevskaya, O. I. Andreytseva, V. T. Ivashkin, A. V. Chzhao, A. G. Serova, G. V. Mikhaylovskaya, I. Yu. Pirogova   +7 more
doaj  

Pathological changes of liver one year later in CHB patients with negative HBV DNA

Infectious Agents and Cancer, 2019
Background In this study, we aim to determine the hepatic pathological changes in HBV DNA-negative chronic Hepatitis B (CHB) patients after 12-month antiviral therapy.
Wu Shanshan, Du Xinfang, Yu Shuihong, Lai Kecong, Qi Jinjin, Chen Zhi, Chen Feng   +6 more
doaj   +1 more source

Interferon treatment in hepatitis B surface antigen‐positive hepatitis B e antibody‐positive chronic hepatitis B: role of hepatitis B core antibody IgM titre in patient selection and treatment monitoring [PDF]

, 1998
S. Lobello, U. Lorenzoni, A. Vian, Annarosa Floreani, Maurizia Rossana Brunetto, M. Chiaramonte   +5 more
openalex   +1 more source

Programmable Nanobody‐Targeting Chimeras Enable Intracellular Viral Protein Degradation

Advanced Science, EarlyView.
Nab‐TAC enables targeted degradation of HBV surface antigen (HBsAg) in vivo. By fusing nanobody‐based recognition domains with programmable proteasome‐recruiting degradation signals, Nab‐TAC reduces HBsAg levels in a hydrodynamic HBV mouse model. ABSTRACT Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because
Max Yu‐Chen Pan, Ting‐Hui Lee, Tzu‐Ning Peng, Eva Yi‐Hsuan Wu, Yu‐Ting Chiu, Chih‐Chien Chiu, Hong Vinh Nguyen, Yuan‐Shao Pao, Ming‐Hong Chao, Richard Kuan‐Lin Lee, Han‐Chung Wu, Lily Hui‐Ching Wang   +11 more
wiley   +1 more source

PREVALÊNCIA DE DOADORES COM MARCADORES DA HEPATITE B DETECTADOS PELA TRIAGEM SOROLÓGICA NO INSTITUTO ONCO-HEMATOLÓGICO DE ANÁPOLIS EM 2012 E 2013

Revista Educação em Saúde, 2015
Objective: To determine the prevalence of serological markers for hepatitis B in blood donors of Instituto Onco-Hematológico de Anápolis, correlating to age, gender and marital status of the donors with the results of serological screening for hepatitis ...
Leonardo Tavares de Oliveira, Rayanne de Deus Guedes, Jozelia Rêgo, Cleonice Maria Garcia de Souza, Thiago Vilarinho Tavares   +4 more
doaj  

The role of expanding the range of donor blood screening in the prevention of posttransfusion hepatitis B

Журнал инфектологии
Introduction. The legislative framework of the Russian Federation does not limit the range of tests used for detection of blood-borne infections. Screening blood donors for anti-HBc antibodies makes it possible to identify donors with potential HBV ...
L. R. Yuzlibaeva, M. A. Patyashina, N. V. Ilina, R. I. Khakimova, K. K. Kyuregyan, M. I. Mikhailov   +5 more
doaj   +1 more source

Chronic HBV Infection Disrupts CCL5‐Secreting cNK Cells and Attenuates Liver Accumulation and Activation of DCs and HBV‐Specific T Cells

Advanced Science, EarlyView.
ADORA2A activation suppresses NFκB‐dependent CCL5 production in cNK cells during chronic HBV infection, disrupting intrahepatic DC recruitment and HBV‐specific CD8+ T‐cell differentiation and function. Targeting the ADORA2A/NFκB/CCL5 axis restores antiviral immunity and facilitates HBV clearance.
Ailu Yang, Yucan Wang, Yating Yu, Jing Wu, Cuiping Bao, Zixuan Wang, Qiuju Han, Zhigang Tian, Jian Zhang, Huajun Zhao   +9 more
wiley   +1 more source

Protective hepatitis B surface antibody (Anti-HBs) levels among health care workers in Duhok city of Iraq

Turkish Journal of Public Health, 2018
Objective: This cross sectional study aimed to find the prevalence of protective hepatitis B surface antibodies (anti-HBs) and HBV infection among health care workers in Duhok city.
Sagvan Hasan Ali, Bakhtiyar Ahmed Rasheed, Tariq Salman Al-Hadithi   +2 more
doaj  

Autoantibodies to Extracellular Erythrocyte Band 3 Epitopes Are Associated With Anemia in Plasmodium vivax Infection

American Journal of Hematology, EarlyView.
ABSTRACT Plasmodium vivax‐associated anemia is a multifactorial clinical outcome, in which the destruction of uninfected red blood cells (uRBCs) plays a major role in disease development and severity. Here, we identified autoantibody targets within the extracellular loops of Band 3 (B3), a major erythrocyte transmembrane protein.
Aline Marzano‐Miranda, Vanessa G. Fraga, Cor Jésus F. Fontes, Simone Ladeia‐Andrade, Marcelo U. Ferreira, Daniella C. Bartholomeu, Érika M. Braga   +6 more
wiley   +1 more source